Previous Page  9 / 12 Next Page
Information
Show Menu
Previous Page 9 / 12 Next Page
Page Background

International Journal of Anesthesiology & Pain Medicine

ISSN: 2471-982X

Volume 4

March 26-28, 2018

Vienna, Austria

Pain Management 2018

Internal Medicine 2018

Page 39

JOINT EVENT

7

t h

E d i t i o n o f I n t e r n a t i o n a l C o n f e r e n c e o n

Internal Medicine and Patient Care

&

6

t h

E d i t i o n o f I n t e r n a t i o n a l C o n f e r e n c e o n

Pain Management

Background:

Sepsis microvascular dysfunction embraces

different cellular components including endothelial cells, in

which it increases its permeability and activation to shed extra

microparticles (MPs) to transport a unique cellular signaling to

the recipient cells. In this study, we observed that microparticles

can retain different epigenetic components as miRNA, mRNA

of DNMTs and HDACs from parent cells that can transfer to

naïve target cells. Importantly, in sepsis, MPs production is

increased. Increased expression of DNMTs results in promoter

hypermethylation which can suppress transcription of not only a

single gene but networks of genes with systemic effects. Sepsis

is an inflammatory insult which can result in vascular dysfunction

leading to systemic shock and eventual death.

Aim:

The aim of this study is to distinguish the role of sepsis

microparticles in systemic immunosuppression process and

the impact of these particles upon cellular targets and survival

mechanisms to allow better diagnostic tools and potential novel

therapeutic approach during infection and trauma.

Methodology:

Endothelial cells ( HUVEC) and naïve monocytes

treated with MPs from patients with sepsis demonstrated

dramatically reduced of anti-inflammatory genes, TGF-β, TNF-α

expression and some of autophagy molecules (ATG5, ATG7

and LC3) due to hypermethylation of their promoter. These data

demonstrate that mRNAs of epigenetic regulators including

DNMTs are highly expressed in plasma MVs in patients with

sepsis and can be transferred to naïve cells through MVs and

cause pro-inflammatory cytokine gene silencing and autophagy

repression in monocytes. Further, MVs per mL plasma on day 1

alone significantly correlated with death by day 5 (r=0.7125 and

p=0.0042). Using immunostaining techniques and flow cytometer,

we found the major source of plasma MVs in the critically-ill, non-

septic control patients shifted frommonocytes (Mo) to endothelial

cells (EC) in the SS patients (Control: Mo 63.6% and EC 7.4% and

SS: Mo 12% and EC 58.7% qualitatively). Focusing our study on

SS patients who lived and SS patients who died by day 5, our data

shows that while total DNMTmRNA copy numbers per plasmaMV

are significantly higher over days 1 and day 3 in those SS patients

who lived, the ratios of DNMT1 (maintenance DNA methylation)

and the combination DNMT3A and DNMT3B (de novo DNA

methylation) are reversed on days 1 and 3 (SS Lived: DNMT3A/3B-

to-DNMT1: day 1=0.68 and day 3=0.87; SS Died: DNMT3A/3B-to-

DNMT1: day 1=2.49 and day 3=2.94). Finally, MV DNMT3A/3B

mRNA from day 1 samples positively correlates with reduced

survival (r=6261 and p=0.0165). Targeting of circulating MVs with

commercially available inhibitors of DNMTs may be a therapeutic

strategy in specific patients with deregulated epigenetic

mechanisms to limit both early and chronic consequences.

Results:

We found that MPs from patients with septic shock and

septic had significantly increased mRNA for DNMTs compared

to MPs from patients with critical illness without sepsis and from

normal healthy adults over the course of 5 days. Remarkably,

we noticed that DNMT1 and -3a mRNA has the highest gene

expression in sepsis MPs compared to other DNMTs. Additionally,

naïve monocytes treated with MPs from patients with sepsis

demonstrated increased expression of DNMTs. At the same time

decreased expression at 24 hours.

Epigenetic re-programming of plasma

microvesicles in sepsis

Duaa Dakhlallah, Jon Wisler, Tierra Ware, Erin

Leatherman, Yijie Wang, Amy Gross, Joyce Obeng,

Ahmad Dakhlallah, Timothy D Eubank and Clay B

Marsh

West Virginia University, USA

Duaa Dakhlallah, Int J Anesth Pain Med 2018, Volume 4

DOI: 10.21767/2471-982X-C1-001